JPRN-UMIN000021137已完成未知
Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy with S-1 after curative treatment in patients with squamous cell carcinoma of the head and neck - Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy with S-1 after curative treatment in patients with squamous cell carcinoma of the head and neck
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with active double cancer (synchronous double cancer and metachronous double cancer) 2) Patient with administration contraindication of S-1 and Lafutidine
研究者
相似试验
已完成
不适用
Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy of Gastric Cancer (AEOLUS)Gastric neoplasmJPRN-UMIN000002703Pharma Valley Center , Shizuoka Industrial Foundation200
尚未招募
不适用
Clinical effect of lafutidine (Protecadin) on the mild case of Reflux Disease (health care economic comparison of which it contrasts Lansoprazole)reflux esophagitisJPRN-UMIN000006162PROMISE study Society160
已完成
4 期
Efficacy of Sitagliptin added to sulfonylurea in subjects with poorly controlled type 2 diabetes (STRICT-1)Type 2 Diabetes MellitusJPRN-UMIN000005178STRICT study Group200
已完成
不适用
The influence of sulfonylurea or dipeptidyl-peptidase-4 inhibitor on glucose control and the secretion of glucagon and insulin induced by sodium glucose transporter-2 inhibitor in type2 diabetic patientsType2 diabetes mellitusJPRN-UMIN000022661Chiba Central Medical Center, Diabetes Center20
已完成
早期 1 期
Lysine therapy of type 2 diabetic patientsType 2 diabetes.Non-insulin-dependent diabetes mellitusIRCT2014120220184N1Iran National Science Foundation (INSF)50